238 related articles for article (PubMed ID: 14729763)
1. In vitro antibacterial activity of the peptide PsVP-10 against antimicrobial-resistant Enterococcus faecalis isolated from clinical samples.
Padilla C; Lobos O; Brevis P; Abaca P; Hubert E
J Antimicrob Chemother; 2004 Feb; 53(2):390-2. PubMed ID: 14729763
[TBL] [Abstract][Full Text] [Related]
2. Cationic peptide of the male reproductive tract, HE2alpha, displays antimicrobial activity against Neisseria gonorrhoeae, Staphylococcus aureus and Enterococcus faecalis.
Liao M; Ruddock PS; Rizvi AS; Hall SH; French FS; Dillon JR
J Antimicrob Chemother; 2005 Nov; 56(5):957-61. PubMed ID: 16195256
[TBL] [Abstract][Full Text] [Related]
3. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial resistance of enterococci in Turkey.
Kaçmaz B; Aksoy A
Int J Antimicrob Agents; 2005 Jun; 25(6):535-8. PubMed ID: 15908184
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
[TBL] [Abstract][Full Text] [Related]
6. [Susceptibility of Enterococcus genus to new antimicrobial agents].
Sánchez-Molina MI; Martín D; Valladares C; Gastañares MJ; Torres C; Borque L
Rev Esp Quimioter; 2004 Jun; 17(2):184-8. PubMed ID: 15470513
[TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy.
Zarrilli R; Tripodi MF; Di Popolo A; Fortunato R; Bagattini M; Crispino M; Florio A; Triassi M; Utili R
J Antimicrob Chemother; 2005 Nov; 56(5):827-35. PubMed ID: 16186168
[TBL] [Abstract][Full Text] [Related]
8. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
Sandoe JA; Wysome J; West AP; Heritage J; Wilcox MH
J Antimicrob Chemother; 2006 Apr; 57(4):767-70. PubMed ID: 16464896
[TBL] [Abstract][Full Text] [Related]
9. Spread of an unusual penicillin- and imipenem-resistant but ampicillin-susceptible phenotype among Enterococcus faecalis clinical isolates.
Metzidie E; Manolis EN; Pournaras S; Sofianou D; Tsakris A
J Antimicrob Chemother; 2006 Jan; 57(1):158-60. PubMed ID: 16308417
[No Abstract] [Full Text] [Related]
10. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
11. Emerging vancomycin resistance in enterococci in India.
Ghoshal U; Garg A; Tiwari DP; Ayyagari A
Indian J Pathol Microbiol; 2006 Oct; 49(4):620-2. PubMed ID: 17183879
[TBL] [Abstract][Full Text] [Related]
12. [Antimicrobial susceptibility of Enterococcus faecalis isolated from patients in Córdoba (Spain)].
Causse M; Franco-Alvarez de Luna F; García-Mayorgas AD; Rodríguez FC; Casal M
Rev Esp Quimioter; 2006 Jun; 19(2):140-3. PubMed ID: 16964331
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide.
Sader HS; Streit JM; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2004 Nov; 50(3):201-4. PubMed ID: 15541606
[TBL] [Abstract][Full Text] [Related]
14. [Drug sensitivity of Enterococcus sp. strains isolated from clinical material or from healthy persons].
Piekarska K; Ławrynowicz-Paciorek M; Magdziak A; Bareja E; Rudecka A; Wyrebiak A; Pietrzyk M; Kochman M
Med Dosw Mikrobiol; 2002; 54(4):305-15. PubMed ID: 12650053
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the in vitro efficacy of the novel antimicrobial peptide CECT7121 against human Gram-positive bacteria from serious infections refractory to treatment.
Sparo MD; Jones DG; Sánchez Bruni SF
Chemotherapy; 2009; 55(4):270-7. PubMed ID: 19494489
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic resistant fecal isolates of Enterococci among unselected patients outside the clinical sector: an epidemiological study from Southern Germany.
Lietzau S; Hoewner M; von Baum H; Marre R; Brenner H
Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):275-7. PubMed ID: 16287198
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance Initiative.
Draghi DC; Benton BM; Krause KM; Thornsberry C; Pillar C; Sahm DF
J Antimicrob Chemother; 2008 Jul; 62(1):116-21. PubMed ID: 18424792
[TBL] [Abstract][Full Text] [Related]
18. Synergistic activity of vancomycin and teicoplanin alone and in combination with streptomycin against Enterococcus faecalis strains with various vancomycin susceptibilities.
Babalola CP; Patel KB; Nightingale CH; Nicolau DP
Int J Antimicrob Agents; 2004 Apr; 23(4):343-8. PubMed ID: 15081082
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of antimicrobial resistance in enterococci of animal origin.
Hershberger E; Oprea SF; Donabedian SM; Perri M; Bozigar P; Bartlett P; Zervos MJ
J Antimicrob Chemother; 2005 Jan; 55(1):127-30. PubMed ID: 15574473
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of Enterococcus faecalis antimicrobial resistance].
Casal MM; Cause M; Solís F; Rodríz F; Casal M
Rev Esp Quimioter; 2009 Sep; 22(3):117-9. PubMed ID: 19662543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
